Nazovell

Nazovell may be available in the countries listed below.

Ingredient matches for Nazovell

Ketoprofen

Ketoprofen is reported as an ingredient of Nazovell in the following countries:

• Indonesia

International Drug Name Search

Dompenyl

Dompenyl may be available in the countries listed below.

Ingredient matches for Dompenyl

Domperidone

Domperidone is reported as an ingredient of Dompenyl in the following countries:

• Philippines

International Drug Name Search

Fragmin

Fragmin is a brand name of dalteparin, approved by the FDA in the following formulation(s):

FRAGMIN (dalteparin sodium - injectable; subcutaneous)

• 
  Manufacturer: EISAI INC
  
  Approval date: December 22, 1994
  
  Strength(s): 2,500IU/0.2ML (12,500IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: March 18, 1996
  
  Strength(s): 5,000IU/0.2ML (25,000IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: January 30, 1998
  
  Strength(s): 10,000IU/ML (10,000IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: April 4, 2002
  
  Strength(s): 7,500IU/0.3ML (25,000IU/ML), 95,000IU/3.8ML (25,000IU/ML) ^[RLD], 95,000IU/9.5ML (10,000IU/ML)
  


• 
  Manufacturer: EISAI INC
  
  Approval date: May 1, 2007
  
  Strength(s): 10,000IU/0.4ML (25,000IU/ML), 12,500IU/0.5ML (25,000IU/ML), 15,000IU/0.6ML (25,000IU/ML), 18,000IU/0.72ML (25,000IU/ML)
  

Has a generic version of Fragmin been approved?

No. There is currently no therapeutically equivalent version of Fragmin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fragmin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Fragmin.

See also...

• Fragmin Consumer Information (Drugs.com)
• Fragmin Consumer Information (Wolters Kluwer)
• Fragmin Consumer Information (Cerner Multum)
• Fragmin Advanced Consumer Information (Micromedex)
• Fragmin AHFS DI Monographs (ASHP)
• Dalteparin Consumer Information (Wolters Kluwer)
• Dalteparin Consumer Information (Cerner Multum)
• Dalteparin Subcutaneous Advanced Consumer Information (Micromedex)
• Dalteparin Sodium AHFS DI Monographs (ASHP)

Zodep

Zodep may be available in the countries listed below.

Ingredient matches for Zodep

Citalopram

Citalopram is reported as an ingredient of Zodep in the following countries:

• Dominican Republic

International Drug Name Search

Ferriprox

Ferriprox is a brand name of deferiprone, approved by the FDA in the following formulation(s):

FERRIPROX (deferiprone - tablet; oral)

• 
  Manufacturer: APOPHARMA INC
  
  Approval date: October 14, 2011
  
  Strength(s): 500MG ^[RLD]

Has a generic version of Ferriprox been approved?

No. There is currently no therapeutically equivalent version of Ferriprox available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ferriprox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ferriprox.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 14, 2016 - NEW CHEMICAL ENTITY
  
  
  • October 14, 2018 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Ferriprox Consumer Information (Drugs.com)
• Ferriprox Consumer Information (Wolters Kluwer)
• Deferiprone Consumer Information (Wolters Kluwer)

Nyaderm

Nyaderm may be available in the countries listed below.

Ingredient matches for Nyaderm

Nystatin

Nystatin is reported as an ingredient of Nyaderm in the following countries:

• Canada

International Drug Name Search

Nexiam IV

Nexiam IV may be available in the countries listed below.

Ingredient matches for Nexiam IV

Esomeprazole

Esomeprazole sodium (a derivative of Esomeprazole) is reported as an ingredient of Nexiam IV in the following countries:

• South Africa

International Drug Name Search